The most important features of our Laser LYCOS (Ver 5.10), LYKOS-DTS (Ver L 6.4) and the ZILOS-tk in a comparison chart! … read more ›
The new movable Lykos laser DTS (Dynamic Targeting SystemTM) is going to be available from us by mid of june 19! Please have a more … read more ›
We are looking forward to welcoming you at our booth E27 at ESHRE 2019 in Vienna, Austria from 23 to 26 June 2019 … read more ›
The packages leaving the Gynemed warehouse are packed with great care and the products contained are best protected against transport damage. Unfortunately, transport damage can … read more ›
It sings for you the Gynemed Christmas Choir a rationalization and shortening model of our most famous german Christmas carols. Have fun! … read more ›
We would like to draw your attention to the new General Terms and Agreements at Gynemed, which take effect on 01. January 2019. Passage 3 … read more ›
Christmas Closure: The Gynemed office and warehouse will be closed from Monday 24th December 2018 until Tuesday 1st January 2019. Our usual service in the office and warehouse will resume on 2nd January 2019. We recommend to place your … read more ›
Also this year Gynemed participates again in the Eshre in Barcelona. With great pleasure, the preparations are under way. We would like to welcome you … read more ›
As in previous editions of ESHRE congresses, this year KITAZATO perform vitrification workshops in your booth. If you are interested, feel free to contact us … read more ›
Big News: We’re Growing!
Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics
product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.
✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service
We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.
Learn More About the Acquisition
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
